Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by SundayMovieson Dec 08, 2022 10:34am
144 Views
Post# 35158924

RE:RE:I got more shares than Matt Coffey! lol!!!

RE:RE:I got more shares than Matt Coffey! lol!!!Davepark5, 


I think their first failure in 2010 is still affecting them. Oncovirus are now better understood and a good way (accepted way scientifically) to treat cancer. 
Matt is the most boring leader ever. His lack of personality is not helping share price but he is what he is...Not sure why partners are not stepping up before? ONCY does have a long lists of interested Pharma and of course Adlai. Well, data before was biomarkers stuff, scientific theory about cell having fun in their pathway. Now things are getting concrete. You got people alive and well. So, I think this is the game changer here. Real stuff. Real People. 

I think the value proposition here is beyond doubt now. I think we get a hostile take over and nothing can stop that - no poison pill nothing. Why partner here if you can just take it over. Pump 30 millions after the take over and reap billions in sales for years... The shareholders are in a coma. Just reading this board indicates capitulation already with no hope. Anyway, I am a trader. I need to make money. 

I think is the best short term trading idea of 2022/23. You put 100K it will mushroom easy to 200K as we get closer Bracelet-1 date.

I also think Theratechnologies (which failed recently their cancer candidate) might be prone to do partner here. Anyway, lots of possitive possibilites.

Share price cannot go but further up... Best of luck to you. All wisht that everyone makes all the money they desire! 

<< Previous
Bullboard Posts
Next >>